首页 › 基金 › Paradigm Biocapital Advisors LP › TNGX
Paradigm Biocapital Advisors LP 对 TNGX 的持仓历史
TANGO THERAPEUTICS INC · 医疗保健
Paradigm Biocapital Advisors LP 在 Q3 2026 的 13F 申报中披露持有 TNGX(TANGO THERAPEUTICS INC)6,961,546 股,市值约 US$173.7M,约占其申报组合的 3.45%,在其申报持仓中市值排名第 11 位。 Paradigm Biocapital Advisors LP 最近 5 个申报季度中有 4 个季度披露了 TNGX 持仓,最早可追溯至 Q3 2025。
最后更新: 2026-11-16 · 来源: SEC EDGAR Form 13F-HR
Paradigm Biocapital Advisors LP 对 TNGX 的持仓演变
Paradigm Biocapital Advisors LP 于 Q3 2025 首次披露 TNGX 持仓:3,086,184 股(约 US$25.9M)。 该持仓在 Q2 2026 达到峰值 6,357,523 股,市值约 US$198.7M。 在 4 次申报中,Paradigm Biocapital Advisors LP 2 次增持、0 次减持、0 次保持不变。 最近一期申报(Q3 2026)显示持股 6,961,546 股、市值约 US$173.7M,环比增持 604,023 股。。 持仓曾出现大幅变动:Q2 2026 增持约 59% (随后一个季度股价下跌 20%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2025 | 3.09M | $25.92M | 新进 |
| Q1 2026 | 4.01M | $83.88M | 新进 |
| Q2 2026 | 6.36M | $198.74M | 增持 |
| Q3 2026 | 6.96M | $173.69M | 增持 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 TNGX 与 13F 数据
TNGX(TANGO THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 69 只申报持有 TNGX,申报仓位最大的包括:法拉龙资本管理 (US$383.8M), RTW INVESTMENTS, LP (US$350.5M), Boxer Capital Management, LLC (US$340.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 TNGX 的基金
- 法拉龙资本管理 12.28M 股 · $383.78M · Q2 2026
- RTW INVESTMENTS, LP 14.05M 股 · $350.51M · Q3 2026
- Boxer Capital Management, LLC 10.88M 股 · $339.99M · Q2 2026
- Siren, L.L.C. 6.78M 股 · $169.26M · Q3 2026
- TCG Crossover Management, LLC 6.77M 股 · $168.99M · Q3 2026
- DEERFIELD MANAGEMENT COMPANY, L.P. 4.19M 股 · $131.00M · Q2 2026
- TRV GP IV, LLC 6.37M 股 · $120.18M · Q2 2026
- FARALLON CAPITAL MANAGEMENT, L.L.C. 4.55M 股 · $113.54M · Q3 2026
- Deep Track Capital, LP 4.50M 股 · $112.28M · Q3 2026
- PERCEPTIVE ADVISORS LLC 3.38M 股 · $105.57M · Q2 2026
- Seven Fleet Capital Management LP 3.23M 股 · $95.66M · Q2 2026
- Caligan Partners LP 2.50M 股 · $78.15M · Q2 2026
更多关于 Paradigm Biocapital Advisors LP
常见问题
How long has Paradigm Biocapital Advisors LP held TNGX?
Paradigm Biocapital Advisors LP has disclosed TNGX holdings in 4 of the last 5 reported quarters, going back to Q3 2025.
What is Paradigm Biocapital Advisors LP's current position in TNGX?
As of Q3 2026, Paradigm Biocapital Advisors LP holds 6.96M shares of TNGX (TANGO THERAPEUTICS INC), valued at $173.69M, representing 3.45% of its reported portfolio and ranking #11.
Has Paradigm Biocapital Advisors LP been buying or selling TNGX?
In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP increased its position in TNGX. The position peaked in Q2 2026 at 6.36M shares.
Which other funds hold TNGX?
Other major institutional holders of TNGX include 法拉龙资本管理, RTW INVESTMENTS, LP, Boxer Capital Management, LLC, among 69 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.